{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:44:03Z","timestamp":1790930643618,"version":"4.1.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T00:00:00Z","timestamp":1279152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00401-010-0719-5","type":"journal-article","created":{"date-parts":[[2010,7,14]],"date-time":"2010-07-14T02:08:00Z","timestamp":1279073280000},"page":"369-384","source":"Crossref","is-referenced-by-count":116,"title":["Neuropathology after active A\u03b242 immunotherapy: implications for Alzheimer\u2019s disease pathogenesis"],"prefix":"10.1007","volume":"120","author":[{"given":"Delphine","family":"Boche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Denham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A. R.","family":"Nicoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,15]]},"reference":[{"key":"719_CR1","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.4049\/jimmunol.174.3.1580","volume":"174","author":"MG Agadjanyan","year":"2005","unstructured":"Agadjanyan MG, Ghochikyan A, Petrushina I et al (2005) Prototype Alzheimer\u2019s disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide. J Immunol 174:1580\u20131586","journal-title":"J Immunol"},{"key":"719_CR2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S et al (2000) Inflammation and Alzheimer\u2019s disease. Neurobiol Aging 21:383\u2013421","journal-title":"Neurobiol Aging"},{"key":"719_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02909305","volume":"12","author":"P Alaupovic","year":"1982","unstructured":"Alaupovic P (1982) The role of apolipoproteins in lipid transport processes. Ric Clin Lab 12:3\u201321","journal-title":"Ric Clin Lab"},{"key":"719_CR4","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1523\/JNEUROSCI.2361-07.2007","volume":"27","author":"AA Asuni","year":"2007","unstructured":"Asuni AA, Boutajangout A, Quartermain D, Sigurdsson EM (2007) Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. J Neurosci 27:9115\u20139129","journal-title":"J Neurosci"},{"key":"719_CR5","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1111\/j.1460-9568.2006.05149.x","volume":"24","author":"AA Asuni","year":"2006","unstructured":"Asuni AA, Boutajangout A, Scholtzova H et al (2006) Vaccination of Alzheimer\u2019s model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages. Eur J Neurosci 24:2530\u20132542","journal-title":"Eur J Neurosci"},{"key":"719_CR6","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1073\/pnas.0436286100","volume":"100","author":"F Bard","year":"2003","unstructured":"Bard F, Barbour R, Cannon C et al (2003) Epitope and isotype specificities of antibodies to beta-amyloid peptide for protection against Alzheimer\u2019s disease-like neuropathology. Proc Natl Acad Sci USA 100:2023\u20132028","journal-title":"Proc Natl Acad Sci USA"},{"key":"719_CR7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","volume":"6","author":"F Bard","year":"2000","unstructured":"Bard F, Cannon C, Barbour R et al (2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6:916\u2013919","journal-title":"Nat Med"},{"key":"719_CR8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/01.WNL.0000148604.77591.67","volume":"64","author":"AJ Bayer","year":"2005","unstructured":"Bayer AJ, Bullock R, Jones RW et al (2005) Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD. Neurology 64:94\u2013101","journal-title":"Neurology"},{"key":"719_CR9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-010-0705-y","volume":"120","author":"D Boche","year":"2010","unstructured":"Boche D, Donald J, Love S et al (2010) Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer\u2019s disease. Acta Neuropathol 120:13\u201320","journal-title":"Acta Neuropathol"},{"key":"719_CR10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1750-3639.2008.00134.x","volume":"18","author":"D Boche","year":"2008","unstructured":"Boche D, Nicoll JA (2008) The role of the immune system in clearance of abeta from the brain. Brain Pathol 18:267\u2013278","journal-title":"Brain Pathol"},{"key":"719_CR11","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/brain\/awn261","volume":"131","author":"D Boche","year":"2008","unstructured":"Boche D, Zotova E, Weller RO et al (2008) Consequence of Abeta immunization on the vasculature of human Alzheimer\u2019s disease brain. Brain 131:3299\u20133310","journal-title":"Brain"},{"key":"719_CR12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archneur.64.4.583","volume":"64","author":"S Bombois","year":"2007","unstructured":"Bombois S, Maurage CA, Gompel M et al (2007) Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia. Arch Neurol 64:583\u2013587","journal-title":"Arch Neurol"},{"key":"719_CR13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0896-6273(00)80974-5","volume":"19","author":"DR Borchelt","year":"1997","unstructured":"Borchelt DR, Ratovitski T, van Lare J et al (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19:939\u2013945","journal-title":"Neuron"},{"key":"719_CR14","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1172\/JCI113943","volume":"83","author":"JK Boyles","year":"1989","unstructured":"Boyles JK, Zoellner CD, Anderson LJ et al (1989) A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 83:1015\u20131031","journal-title":"J Clin Invest"},{"key":"719_CR15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1172\/JCI23269","volume":"115","author":"RP Brendza","year":"2005","unstructured":"Brendza RP, Bacskai BJ, Cirrito JR et al (2005) Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice. J Clin Invest 115:428\u2013433","journal-title":"J Clin Invest"},{"key":"719_CR16","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1523\/JNEUROSCI.1697-05.2005","volume":"25","author":"M Buttini","year":"2005","unstructured":"Buttini M, Masliah E, Barbour R et al (2005) Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer\u2019s disease. J Neurosci 25:9096\u20139101","journal-title":"J Neurosci"},{"key":"719_CR17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2990.2007.00926.x","volume":"34","author":"RO Carare","year":"2008","unstructured":"Carare RO, Bernardes-Silva M, Newman TA et al (2008) Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol 34:131\u2013144","journal-title":"Neuropathol Appl Neurobiol"},{"key":"719_CR18","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1194\/jlr.R300010-JLR200","volume":"44","author":"NB Chauhan","year":"2003","unstructured":"Chauhan NB (2003) Membrane dynamics, cholesterol homeostasis, and Alzheimer\u2019s disease. J Lipid Res 44:2019\u20132029","journal-title":"J Lipid Res"},{"key":"719_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ca.20887","volume":"23","author":"R Clapham","year":"2010","unstructured":"Clapham R, O\u2019Sullivan E, Weller RO, Carare RO (2010) Cervical lymph nodes are found in direct relationship with the internal carotid artery: significance for the lymphatic drainage of the brain. Clin Anat 23:43\u201347","journal-title":"Clin Anat"},{"key":"719_CR20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera F, Bolmont T, Crowther RA et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909\u2013913","journal-title":"Nat Cell Biol"},{"key":"719_CR21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-510X(87)90057-8","volume":"78","author":"CA Davies","year":"1987","unstructured":"Davies CA, Mann DM, Sumpter PQ, Yates PO (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer\u2019s disease. J Neurol Sci 78:151\u2013164","journal-title":"J Neurol Sci"},{"key":"719_CR22","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","volume":"98","author":"RB DeMattos","year":"2001","unstructured":"DeMattos RB, Bales KR, Cummins DJ et al (2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA 98:8850\u20138855","journal-title":"Proc Natl Acad Sci USA"},{"key":"719_CR23","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1126\/science.1067568","volume":"295","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM (2002) Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer\u2019s disease. Science 295:2264\u20132267","journal-title":"Science"},{"key":"719_CR24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1471-4159.2002.00889.x","volume":"81","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB, Bales KR, Parsadanian M et al (2002) Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer\u2019s disease. J Neurochem 81:229\u2013236","journal-title":"J Neurochem"},{"key":"719_CR25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ana.10810","volume":"55","author":"JA Eng","year":"2004","unstructured":"Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM (2004) Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 55:250\u2013256","journal-title":"Ann Neurol"},{"key":"719_CR26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1750-3639.2004.tb00493.x","volume":"14","author":"I Ferrer","year":"2004","unstructured":"Ferrer I, Boada Rovira M, Sanchez Guerra ML, Rey MJ, Costa-Jussa F (2004) Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer\u2019s disease. Brain Pathol 14:11\u201320","journal-title":"Brain Pathol"},{"key":"719_CR27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/hmg\/1.3.165","volume":"1","author":"L Fidani","year":"1992","unstructured":"Fidani L, Rooke K, Chartier-Harlin MC et al (1992) Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer\u2019s disease: identification of a further family with APP717 Val\u2192Ile. Hum Mol Genet 1:165\u2013168","journal-title":"Hum Mol Genet"},{"key":"719_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"719_CR29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","volume":"373","author":"D Games","year":"1995","unstructured":"Games D, Adams D, Alessandrini R et al (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373:523\u2013527","journal-title":"Nature"},{"key":"719_CR30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1749-6632.2000.tb06936.x","volume":"920","author":"D Games","year":"2000","unstructured":"Games D, Bard F, Grajeda H et al (2000) Prevention and reduction of AD-type pathology in PDAPP mice immunized with A beta 1\u201342. Ann N Y Acad Sci 920:274\u2013284","journal-title":"Ann N Y Acad Sci"},{"key":"719_CR31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.forsciint.2004.06.027","volume":"146","author":"SM Gentleman","year":"2004","unstructured":"Gentleman SM, Leclercq PD, Moyes L et al (2004) Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int 146:97\u2013104","journal-title":"Forensic Sci Int"},{"key":"719_CR32","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","volume":"64","author":"S Gilman","year":"2005","unstructured":"Gilman S, Koller M, Black RS et al (2005) Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 64:1553\u20131562","journal-title":"Neurology"},{"key":"719_CR33","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","volume":"100","author":"Y Gong","year":"2003","unstructured":"Gong Y, Chang L, Viola KL et al (2003) Alzheimer\u2019s disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci USA 100:10417\u201310422","journal-title":"Proc Natl Acad Sci USA"},{"key":"719_CR34","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1212\/WNL.51.3.690","volume":"51","author":"SM Greenberg","year":"1998","unstructured":"Greenberg SM (1998) Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology 51:690\u2013694","journal-title":"Neurology"},{"key":"719_CR35","doi-asserted-by":"crossref","first-page":"470S","DOI":"10.1093\/ajcn\/83.2.470S","volume":"83","author":"WS Griffin","year":"2006","unstructured":"Griffin WS (2006) Inflammation and neurodegenerative diseases. Am J Clin Nutr 83:470S\u2013474S","journal-title":"Am J Clin Nutr"},{"key":"719_CR36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1750-3639.1998.tb00136.x","volume":"8","author":"WS Griffin","year":"1998","unstructured":"Griffin WS, Sheng JG, Royston MC et al (1998) Glial-neuronal interactions in Alzheimer\u2019s disease: the potential role of a \u2018cytokine cycle\u2019 in disease progression. Brain Pathol 8:65\u201372","journal-title":"Brain Pathol"},{"key":"719_CR37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ana.410360307","volume":"36","author":"M Haltia","year":"1994","unstructured":"Haltia M, Viitanen M, Sulkava R et al (1994) Chromosome 14-encoded Alzheimer\u2019s disease: genetic and clinicopathological description. Ann Neurol 36:362\u2013367","journal-title":"Ann Neurol"},{"key":"719_CR38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci 12:383\u2013388","journal-title":"Trends Pharmacol Sci"},{"key":"719_CR39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356","journal-title":"Science"},{"key":"719_CR40","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1001\/archpsyc.1977.01770200114017","volume":"34","author":"LL Heston","year":"1977","unstructured":"Heston LL, Mastri AR (1977) The genetics of Alzheimer\u2019s disease: associations with hematologic malignancy and Down\u2019s syndrome. Arch Gen Psychiatry 34:976\u2013981","journal-title":"Arch Gen Psychiatry"},{"key":"719_CR41","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0896-6273(03)00294-0","volume":"38","author":"C Hock","year":"2003","unstructured":"Hock C, Konietzko U, Streffer JR et al (2003) Antibodies against beta-amyloid slow cognitive decline in Alzheimer\u2019s disease. Neuron 38:547\u2013554","journal-title":"Neuron"},{"key":"719_CR42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm0198-097","volume":"4","author":"L Holcomb","year":"1998","unstructured":"Holcomb L, Gordon MN, McGowan E et al (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4:97\u2013100","journal-title":"Nat Med"},{"key":"719_CR43","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","volume":"372","author":"C Holmes","year":"2008","unstructured":"Holmes C, Boche D, Wilkinson D et al (2008) Long term effect of Abeta42 immunization in Alzheimer\u2019s disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372:216\u2013223","journal-title":"Lancet"},{"key":"719_CR44","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1172\/JCI6179","volume":"103","author":"DM Holtzman","year":"1999","unstructured":"Holtzman DM, Bales KR, Wu S et al (1999) Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer\u2019s disease. J Clin Invest 103:R15\u2013R21","journal-title":"J Clin Invest"},{"key":"719_CR45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S et al (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99\u2013102","journal-title":"Science"},{"key":"719_CR46","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jnr.20886","volume":"84","author":"G Istrin","year":"2006","unstructured":"Istrin G, Bosis E, Solomon B (2006) Intravenous immunoglobulin enhances the clearance of fibrillar amyloid-beta peptide. J Neurosci Res 84:434\u2013443","journal-title":"J Neurosci Res"},{"key":"719_CR47","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/35050110","volume":"408","author":"C Janus","year":"2000","unstructured":"Janus C, Pearson J, McLaurin J et al (2000) Abeta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer\u2019s disease. Nature 408:979\u2013982","journal-title":"Nature"},{"key":"719_CR48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00062752-199901000-00004","volume":"6","author":"RN Kalaria","year":"1999","unstructured":"Kalaria RN (1999) Microglia and Alzheimer\u2019s disease. Curr Opin Hematol 6:15\u201324","journal-title":"Curr Opin Hematol"},{"key":"719_CR49","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1212\/WNL.42.8.1445","volume":"42","author":"H Karlinsky","year":"1992","unstructured":"Karlinsky H, Vaula G, Haines JL et al (1992) Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer\u2019s disease and a missense mutation in codon 717 of the beta-amyloid precursor protein gene. Neurology 42:1445\u20131453","journal-title":"Neurology"},{"key":"719_CR50","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.vaccine.2004.12.015","volume":"23","author":"HD Kim","year":"2005","unstructured":"Kim HD, Cao Y, Kong FK et al (2005) Induction of a Th2 immune response by co-administration of recombinant adenovirus vectors encoding amyloid beta-protein and GM-CSF. Vaccine 23:2977\u20132986","journal-title":"Vaccine"},{"key":"719_CR51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1326-4-21","volume":"4","author":"KM Korwek","year":"2009","unstructured":"Korwek KM, Trotter JH, Ladu MJ, Sullivan PM, Weeber EJ (2009) ApoE isoform-dependent changes in hippocampal synaptic function. Mol Neurodegener 4:21","journal-title":"Mol Neurodegener"},{"key":"719_CR52","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1097\/00001756-199707280-00018","volume":"8","author":"HJ Krugers","year":"1997","unstructured":"Krugers HJ, Mulder M, Korf J et al (1997) Altered synaptic plasticity in hippocampal CA1 area of apolipoprotein E deficient mice. Neuroreport 8:2505\u20132510","journal-title":"Neuroreport"},{"key":"719_CR53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0166-4328(95)00215-4","volume":"78","author":"H Lassmann","year":"1996","unstructured":"Lassmann H (1996) Patterns of synaptic and nerve cell pathology in Alzheimer\u2019s disease. Behav Brain Res 78:9\u201314","journal-title":"Behav Brain Res"},{"key":"719_CR54","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0698-730","volume":"4","author":"SJ Lee","year":"1998","unstructured":"Lee SJ, Liyanage U, Bickel PE et al (1998) A detergent-insoluble membrane compartment contains A beta in vivo. Nat Med 4:730\u2013734","journal-title":"Nat Med"},{"key":"719_CR55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrneurol.2009.219","volume":"6","author":"CA Lemere","year":"2010","unstructured":"Lemere CA, Masliah E (2010) Can Alzheimer disease be prevented by amyloid-beta immunotherapy? Nat Rev Neurol 6:108\u2013119","journal-title":"Nat Rev Neurol"},{"key":"719_CR56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0969-9961(03)00044-5","volume":"14","author":"CA Lemere","year":"2003","unstructured":"Lemere CA, Spooner ET, LaFrancois J et al (2003) Evidence for peripheral clearance of cerebral Abeta protein following chronic, active Abeta immunization in PSAPP mice. Neurobiol Dis 14:10\u201318","journal-title":"Neurobiol Dis"},{"key":"719_CR57","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1471-4159.2005.03441.x","volume":"95","author":"O Levi","year":"2005","unstructured":"Levi O, Lutjohann D, Devir A et al (2005) Regulation of hippocampal cholesterol metabolism by apoE and environmental stimulation. J Neurochem 95:987\u2013997","journal-title":"J Neurochem"},{"key":"719_CR58","doi-asserted-by":"crossref","first-page":"10879","DOI":"10.1523\/JNEUROSCI.23-34-10879.2003","volume":"23","author":"JA Lombardo","year":"2003","unstructured":"Lombardo JA, Stern EA, McLellan ME et al (2003) Amyloid-beta antibody treatment leads to rapid normalization of plaque-induced neuritic alterations. J Neurosci 23:10879\u201310883","journal-title":"J Neurosci"},{"key":"719_CR59","first-page":"1031","volume-title":"Greenfield\u2019s neuropathology","author":"J Lowe","year":"2008","unstructured":"Lowe J, Mirra SS, Hyman BT, Dickson DW (2008) Ageing and dementia. In: Love S, Louis DN, Ellison DW (eds) Greenfield\u2019s neuropathology, 8th edn. Edward Arnold Ltd, London, pp 1031\u20131152","edition":"8"},{"key":"719_CR60","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/bip.20160","volume":"76","author":"M Manea","year":"2004","unstructured":"Manea M, Mezo G, Hudecz F, Przybylski M (2004) Polypeptide conjugates comprising a beta-amyloid plaque-specific epitope as new vaccine structures against Alzheimer\u2019s disease. Biopolymers 76:503\u2013511","journal-title":"Biopolymers"},{"key":"719_CR61","first-page":"509","volume":"10","author":"E Masliah","year":"1995","unstructured":"Masliah E (1995) Mechanisms of synaptic dysfunction in Alzheimer\u2019s disease. Histol Histopathol 10:509\u2013519","journal-title":"Histol Histopathol"},{"key":"719_CR62","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.WNL.0000148590.39911.DF","volume":"64","author":"E Masliah","year":"2005","unstructured":"Masliah E, Hansen L, Adame A et al (2005) Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology 64:129\u2013131","journal-title":"Neurology"},{"key":"719_CR63","first-page":"235","volume":"138","author":"E Masliah","year":"1991","unstructured":"Masliah E, Terry RD, Alford M, DeTeresa R, Hansen LA (1991) Cortical and subcortical patterns of synaptophysin like immunoreactivity in Alzheimer\u2019s disease. Am J Pathol 138:235\u2013246","journal-title":"Am J Pathol"},{"key":"719_CR64","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","volume":"294","author":"DH Mauch","year":"2001","unstructured":"Mauch DH, Nagler K, Schumacher S et al (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science 294:1354\u20131357","journal-title":"Science"},{"key":"719_CR65","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/brain\/awq065","volume":"133","author":"JM McDonald","year":"2010","unstructured":"McDonald JM, Savva GM, Brayne C et al (2010) The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain 133:1328\u20131341","journal-title":"Brain"},{"key":"719_CR66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(87)90696-3","volume":"79","author":"PL McGeer","year":"1987","unstructured":"McGeer PL, Itagaki S, Tago H, McGeer EG (1987) Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 79:195\u2013200","journal-title":"Neurosci Lett"},{"key":"719_CR67","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/nm790","volume":"8","author":"J McLaurin","year":"2002","unstructured":"McLaurin J, Cecal R, Kierstead ME et al (2002) Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4\u201310 and inhibit cytotoxicity and fibrillogenesis. Nat Med 8:1263\u20131269","journal-title":"Nat Med"},{"key":"719_CR68","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/35050116","volume":"408","author":"D Morgan","year":"2000","unstructured":"Morgan D, Diamond DM, Gottschall PE et al (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer\u2019s disease. Nature 408:982\u2013985","journal-title":"Nature"},{"key":"719_CR69","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1096\/fj.06-7685com","volume":"21","author":"A Mouri","year":"2007","unstructured":"Mouri A, Noda Y, Hara H et al (2007) Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model. FASEB J 21:2135\u20132148","journal-title":"FASEB J"},{"key":"719_CR70","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neurobiolaging.2004.05.010","volume":"26","author":"RE Mrak","year":"2005","unstructured":"Mrak RE, Griffin WS (2005) Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 26:349\u2013354","journal-title":"Neurobiol Aging"},{"key":"719_CR71","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0892-345","volume":"1","author":"M Mullan","year":"1992","unstructured":"Mullan M, Crawford F, Axelman K et al (1992) A pathogenic mutation for probable Alzheimer\u2019s disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1:345\u2013347","journal-title":"Nat Genet"},{"key":"719_CR72","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/ng1292-340","volume":"2","author":"M Mullan","year":"1992","unstructured":"Mullan M, Houlden H, Windelspecht M et al (1992) A locus for familial early-onset Alzheimer\u2019s disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene. Nat Genet 2:340\u2013342","journal-title":"Nat Genet"},{"key":"719_CR73","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0140-6736(91)91612-X","volume":"337","author":"S Naruse","year":"1991","unstructured":"Naruse S, Igarashi S, Kobayashi H et al (1991) Mis-sense mutation Val\u2013Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer\u2019s disease. Lancet 337:978\u2013979","journal-title":"Lancet"},{"key":"719_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","volume":"68","author":"PT Nelson","year":"2009","unstructured":"Nelson PT, Braak H, Markesbery WR (2009) Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol 68:1\u201314","journal-title":"J Neuropathol Exp Neurol"},{"key":"719_CR75","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jalz.2009.02.006","volume":"5","author":"K Nichol","year":"2009","unstructured":"Nichol K, Deeny SP, Seif J, Camaclang K, Cotman CW (2009) Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice. Alzheimer\u2019s Dement 5:287\u2013294","journal-title":"Alzheimer\u2019s Dement"},{"key":"719_CR76","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/01.jnen.0000240466.10758.ce","volume":"65","author":"JA Nicoll","year":"2006","unstructured":"Nicoll JA, Barton E, Boche D et al (2006) Abeta species removal after Abeta42 immunization. J Neuropathol Exp Neurol 65:1040\u20131048","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Suppl 1","key":"719_CR77","first-page":"51","volume":"8","author":"JA Nicoll","year":"2001","unstructured":"Nicoll JA, McCarron MO (2001) APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage. Amyloid 8(Suppl 1):51\u201355","journal-title":"Amyloid"},{"key":"719_CR78","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","volume":"9","author":"JA Nicoll","year":"2003","unstructured":"Nicoll JA, Wilkinson D, Holmes C et al (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 9:448\u2013452","journal-title":"Nat Med"},{"key":"719_CR79","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neurobiolaging.2004.02.003","volume":"25","author":"JA Nicoll","year":"2004","unstructured":"Nicoll JA, Yamada M, Frackowiak J, Mazur-Kolecka B, Weller RO (2004) Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer\u2019s disease. Pro-CAA position statement. Neurobiol Aging 25:589\u2013597 (discussion 603\u2013604)","journal-title":"Neurobiol Aging"},{"key":"719_CR80","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neulet.2008.05.117","volume":"441","author":"I Nwosu","year":"2008","unstructured":"Nwosu I, Gairhe S, Struble RG, Nathan BP (2008) Impact of apoE deficiency during synaptic remodeling in the mouse olfactory bulb. Neurosci Lett 441:282\u2013285","journal-title":"Neurosci Lett"},{"key":"719_CR81","doi-asserted-by":"crossref","first-page":"39413","DOI":"10.1074\/jbc.M608485200","volume":"281","author":"S Oddo","year":"2006","unstructured":"Oddo S, Vasilevko V, Caccamo A et al (2006) Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J Biol Chem 281:39413\u201339423","journal-title":"J Biol Chem"},{"key":"719_CR82","unstructured":"Oh JY, Nam YJ, Jo A et al (2010) Apolipoprotein (APOE) mRNA is transported to dendrites and may have a role in synaptic structural plasticity. J Neurochem [Epub ahead of print] 2010 April 28. doi: 10.1111\/j.1471-4159.2010.06773"},{"key":"719_CR83","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","volume":"61","author":"JM Orgogozo","year":"2003","unstructured":"Orgogozo JM, Gilman S, Dartigues JF et al (2003) Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 61:46\u201354","journal-title":"Neurology"},{"key":"719_CR84","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2353\/ajpath.2006.060269","volume":"169","author":"RL Patton","year":"2006","unstructured":"Patton RL, Kalback WM, Esh CL et al (2006) Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer\u2019s disease patients: a biochemical analysis. Am J Pathol 169:1048\u20131063","journal-title":"Am J Pathol"},{"key":"719_CR85","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","volume":"6","author":"VH Perry","year":"2010","unstructured":"Perry VH, Nicoll JA, Holmes C (2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6:193\u2013201","journal-title":"Nat Rev Neurol"},{"key":"719_CR86","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.1078259","volume":"298","author":"M Pfeifer","year":"2002","unstructured":"Pfeifer M, Boncristiano S, Bondolfi L et al (2002) Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science 298:1379","journal-title":"Science"},{"key":"719_CR87","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.2000.tb05564.x","volume":"924","author":"J Poirier","year":"2000","unstructured":"Poirier J (2000) Apolipoprotein E and Alzheimer\u2019s disease. A role in amyloid catabolism. Ann N Y Acad Sci 924:81\u201390","journal-title":"Ann N Y Acad Sci"},{"key":"719_CR88","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1523\/JNEUROSCI.5426-06.2007","volume":"27","author":"CM Prada","year":"2007","unstructured":"Prada CM, Garcia-Alloza M, Betensky RA et al (2007) Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging. J Neurosci 27:1973\u20131980","journal-title":"J Neurosci"},{"key":"719_CR89","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000113700","volume":"5","author":"M Pride","year":"2008","unstructured":"Pride M, Seubert P, Grundman M et al (2008) Progress in the active immunotherapeutic approach to Alzheimer\u2019s disease: clinical investigations into AN1792-associated meningoencephalitis. Neurodegener Dis 5:194\u2013196","journal-title":"Neurodegener Dis"},{"key":"719_CR90","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/archneur.61.12.1859","volume":"61","author":"B Qu","year":"2004","unstructured":"Qu B, Rosenberg RN, Li L, Boyer PJ, Johnston SA (2004) Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease. Arch Neurol 61:1859\u20131864","journal-title":"Arch Neurol"},{"key":"719_CR91","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.immunol.021908.132528","volume":"27","author":"RM Ransohoff","year":"2009","unstructured":"Ransohoff RM, Perry VH (2009) Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27:119\u2013145","journal-title":"Annu Rev Immunol"},{"key":"719_CR92","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF03402043","volume":"9","author":"AE Roher","year":"2003","unstructured":"Roher AE, Kuo YM, Esh C et al (2003) Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer\u2019s disease. Mol Med 9:112\u2013122","journal-title":"Mol Med"},{"key":"719_CR93","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux A, Hannequin D, Raux G et al (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38:24\u201326","journal-title":"Nat Genet"},{"key":"719_CR94","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","volume":"73","author":"S Salloway","year":"2009","unstructured":"Salloway S, Sperling R, Gilman S et al (2009) A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 73:2061\u20132070","journal-title":"Neurology"},{"key":"719_CR95","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1074\/jbc.M006886200","volume":"276","author":"N Sato","year":"2001","unstructured":"Sato N, Imaizumi K, Manabe T et al (2001) Increased production of beta-amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2. J Biol Chem 276:2108\u20132114","journal-title":"J Biol Chem"},{"key":"719_CR96","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/science.1411576","volume":"258","author":"GD Schellenberg","year":"1992","unstructured":"Schellenberg GD, Bird TD, Wijsman EM et al (1992) Genetic linkage evidence for a familial Alzheimer\u2019s disease locus on chromosome 14. Science 258:668\u2013671","journal-title":"Science"},{"key":"719_CR97","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"D Schenk","year":"1999","unstructured":"Schenk D, Barbour R, Dunn W et al (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173\u2013177","journal-title":"Nature"},{"key":"719_CR98","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.coi.2004.07.012","volume":"16","author":"D Schenk","year":"2004","unstructured":"Schenk D, Hagen M, Seubert P (2004) Current progress in beta-amyloid immunotherapy. Curr Opin Immunol 16:599\u2013606","journal-title":"Curr Opin Immunol"},{"key":"719_CR99","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/brain\/awh379","volume":"128","author":"NJ Scolding","year":"2005","unstructured":"Scolding NJ, Joseph F, Kirby PA et al (2005) Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 128:500\u2013515","journal-title":"Brain"},{"key":"719_CR100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ (2002) Alzheimer\u2019s disease is a synaptic failure. Science 298:789\u2013791","journal-title":"Science"},{"key":"719_CR101","doi-asserted-by":"crossref","unstructured":"Serrano-Pozo A, Williams MW, Ferrer I et al (2010) Beneficial effect of human anti-A\u03b2 active immunization on neurite morphology and tau pathology. Brain 133:1312\u20131327","DOI":"10.1093\/brain\/awq056"},{"key":"719_CR102","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","volume":"27","author":"GM Shankar","year":"2007","unstructured":"Shankar GM, Bloodgood BL, Townsend M et al (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866\u20132875","journal-title":"J Neurosci"},{"key":"719_CR103","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2174\/156720509789207930","volume":"6","author":"EM Sigurdsson","year":"2009","unstructured":"Sigurdsson EM (2009) Tau-focused immunotherapy for Alzheimer\u2019s disease and related tauopathies. Curr Alzheimer Res 6:446\u2013450","journal-title":"Curr Alzheimer Res"},{"key":"719_CR104","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1523\/JNEUROSCI.1344-04.2004","volume":"24","author":"EM Sigurdsson","year":"2004","unstructured":"Sigurdsson EM, Knudsen E, Asuni A et al (2004) An attenuated immune response is sufficient to enhance cognition in an Alzheimer\u2019s disease mouse model immunized with amyloid-beta derivatives. J Neurosci 24:6277\u20136282","journal-title":"J Neurosci"},{"key":"719_CR105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9440(10)61715-4","volume":"159","author":"EM Sigurdsson","year":"2001","unstructured":"Sigurdsson EM, Scholtzova H, Mehta PD, Frangione B, Wisniewski T (2001) Immunization with a nontoxic\/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer\u2019s disease-associated pathology in transgenic mice. Am J Pathol 159:439\u2013447","journal-title":"Am J Pathol"},{"key":"719_CR106","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1093\/brain\/awl203","volume":"129","author":"K Sleegers","year":"2006","unstructured":"Sleegers K, Brouwers N, Gijselinck I et al (2006) APP duplication is sufficient to cause early onset Alzheimer\u2019s dementia with cerebral amyloid angiopathy. Brain 129:2977\u20132983","journal-title":"Brain"},{"key":"719_CR107","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1073\/pnas.94.8.4109","volume":"94","author":"B Solomon","year":"1997","unstructured":"Solomon B, Koppel R, Frankel D, Hanan-Aharon E (1997) Disaggregation of Alzheimer beta-amyloid by site-directed mAb. Proc Natl Acad Sci USA 94:4109\u20134112","journal-title":"Proc Natl Acad Sci USA"},{"key":"719_CR108","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ng0593-10","volume":"4","author":"S Sorbi","year":"1993","unstructured":"Sorbi S, Nacmias B, Forleo P et al (1993) APP717 and Alzheimer\u2019s disease in Italy. Nat Genet 4:10","journal-title":"Nat Genet"},{"key":"719_CR109","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.2880399","volume":"235","author":"PH St George-Hyslop","year":"1987","unstructured":"St George-Hyslop PH, Tanzi RE, Polinsky RJ et al (1987) The genetic defect causing familial Alzheimer\u2019s disease maps on chromosome 21. Science 235:885\u2013890","journal-title":"Science"},{"key":"719_CR110","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D et al (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977\u20131981","journal-title":"Proc Natl Acad Sci USA"},{"key":"719_CR111","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","volume":"94","author":"C Sturchler-Pierrat","year":"1997","unstructured":"Sturchler-Pierrat C, Abramowski D, Duke M et al (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94:13287\u201313292","journal-title":"Proc Natl Acad Sci USA"},{"key":"719_CR112","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00005072-199708000-00011","volume":"56","author":"CI Sze","year":"1997","unstructured":"Sze CI, Troncoso JC, Kawas C et al (1997) Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol 56:933\u2013944","journal-title":"J Neuropathol Exp Neurol"},{"key":"719_CR113","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP et al (1991) Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572\u2013580","journal-title":"Ann Neurol"},{"key":"719_CR114","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nbd.2009.05.024","volume":"35","author":"JL Tomic","year":"2009","unstructured":"Tomic JL, Pensalfini A, Head E, Glabe CG (2009) Soluble fibrillar oligomer levels are elevated in Alzheimer\u2019s disease brain and correlate with cognitive dysfunction. Neurobiol Dis 35:352\u2013358","journal-title":"Neurobiol Dis"},{"key":"719_CR115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng1292-335","volume":"2","author":"C Broeckhoven Van","year":"1992","unstructured":"Van Broeckhoven C, Backhovens H, Cruts M et al (1992) Mapping of a gene predisposing to early-onset Alzheimer\u2019s disease to chromosome 14q24.3. Nat Genet 2:335\u2013339","journal-title":"Nat Genet"},{"key":"719_CR116","unstructured":"van Helmond Z, Boche D, Nicoll J et al (2009) Oligomeric A beta levels following A beta(42) immunisation. Neuropathol Appl Neurobiol 35:25"},{"key":"719_CR117","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3940(98)00399-1","volume":"249","author":"I Veinbergs","year":"1998","unstructured":"Veinbergs I, Jung MW, Young SJ et al (1998) Altered long-term potentiation in the hippocampus of apolipoprotein E-deficient mice. Neurosci Lett 249:71\u201374","journal-title":"Neurosci Lett"},{"key":"719_CR118","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV et al (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535\u2013539","journal-title":"Nature"},{"key":"719_CR119","first-page":"50","volume-title":"Cerebrovascular diseases","author":"RO Weller","year":"2005","unstructured":"Weller RO (2005) Drainage pathways of CSF and interstitial fluid. In: Kalimo H (ed) Cerebrovascular diseases. ISN Neuropath Press, Basel, pp 50\u201355"},{"key":"719_CR120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00401-009-0498-z","volume":"118","author":"RO Weller","year":"2009","unstructured":"Weller RO, Boche D, Nicoll JA (2009) Microvasculature changes and cerebral amyloid angiopathy in Alzheimer\u2019s disease and their potential impact on therapy. Acta Neuropathol 118:87\u2013102","journal-title":"Acta Neuropathol"},{"key":"719_CR121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0457-0","volume":"117","author":"RO Weller","year":"2009","unstructured":"Weller RO, Djuanda E, Yow HY, Carare RO (2009) Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol 117:1\u201314","journal-title":"Acta Neuropathol"},{"key":"719_CR122","doi-asserted-by":"crossref","unstructured":"Weller RO, Galea I, Carare RO, Minagar A (2009) Pathophysiology of the lymphatic drainage of the central nervous system: implications for pathogenesis and therapy of multiple sclerosis. Pathophysiology [Epub ahead of print] 2009 Nov 30. doi: 10.1016\/j.pathophys.2009.10.007","DOI":"10.1016\/j.pathophys.2009.10.007"},{"key":"719_CR123","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/87839","volume":"7","author":"SC Weninger","year":"2001","unstructured":"Weninger SC, Yankner BA (2001) Inflammation and Alzheimer disease: the good, the bad, and the ugly. Nat Med 7:527\u2013528","journal-title":"Nat Med"},{"key":"719_CR124","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1159\/000217729","volume":"27","author":"SB Wharton","year":"2009","unstructured":"Wharton SB, O\u2019Callaghan JP, Savva GM et al (2009) Population variation in glial fibrillary acidic protein levels in brain ageing: relationship to Alzheimer-type pathology and dementia. Dement Geriatr Cogn Disord 27:465\u2013473","journal-title":"Dement Geriatr Cogn Disord"},{"key":"719_CR125","doi-asserted-by":"crossref","first-page":"7957","DOI":"10.1523\/JNEUROSCI.1339-09.2009","volume":"29","author":"DM Wilcock","year":"2009","unstructured":"Wilcock DM, Gharkholonarehe N, Van Nostrand WE et al (2009) Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer\u2019s disease. J Neurosci 29:7957\u20137965","journal-title":"J Neurosci"},{"key":"719_CR126","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-2094-1-24","volume":"1","author":"DM Wilcock","year":"2004","unstructured":"Wilcock DM, Rojiani A, Rosenthal A et al (2004) Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflamm 1:24","journal-title":"J Neuroinflamm"},{"key":"719_CR127","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(08)70170-4","volume":"7","author":"T Wisniewski","year":"2008","unstructured":"Wisniewski T, Konietzko U (2008) Amyloid-beta immunisation for Alzheimer\u2019s disease. Lancet Neurol 7:805\u2013811","journal-title":"Lancet Neurol"},{"key":"719_CR128","doi-asserted-by":"crossref","first-page":"11223","DOI":"10.1021\/bi991080q","volume":"38","author":"MS Wolfe","year":"1999","unstructured":"Wolfe MS, De Los Angeles J, Miller DD, Xia W, Selkoe DJ (1999) Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer\u2019s disease. Biochemistry 38:11223\u201311230","journal-title":"Biochemistry"},{"key":"719_CR129","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0006-291X(91)91011-Z","volume":"178","author":"K Yoshioka","year":"1991","unstructured":"Yoshioka K, Miki T, Katsuya T, Ogihara T, Sakaki Y (1991) The 717Val\u2013Ile substitution in amyloid precursor protein is associated with familial Alzheimer\u2019s disease regardless of ethnic groups. Biochem Biophys Res Commun 178:1141\u20131146","journal-title":"Biochem Biophys Res Commun"},{"key":"719_CR130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2217\/bmm.09.80","volume":"4","author":"H Zetterberg","year":"2010","unstructured":"Zetterberg H, Mattsson N, Shaw LM, Blennow K (2010) Biochemical markers in Alzheimer\u2019s disease clinical trials. Biomark Med 4:91\u201398","journal-title":"Biomark Med"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-010-0719-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-010-0719-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-010-0719-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T05:04:01Z","timestamp":1711602241000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-010-0719-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,15]]},"references-count":130,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["719"],"URL":"https:\/\/doi.org\/10.1007\/s00401-010-0719-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.4848960.4774059","asserted-by":"object"}]},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,15]]}}}